$CAH
CARDINAL HEALTH INC

2021 Q4 Form 10-Q Financial Statement

#000072137122000013 Filed on February 03, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4 2020 Q2
Revenue $45.46B $41.54B $36.69B
YoY Change 9.43% 4.55% -1.78%
Cost Of Revenue $43.84B $39.77B $35.10B
YoY Change 10.25% 4.59% -1.63%
Gross Profit $1.616B $1.776B $1.590B
YoY Change -9.01% 3.62% -5.02%
Gross Profit Margin 3.56% 4.28% 4.33%
Selling, General & Admin $1.151B $1.147B $1.137B
YoY Change 0.35% -1.38% -2.65%
% of Gross Profit 71.23% 64.58% 71.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $164.0M $199.0M $225.0M
YoY Change -17.59% -13.48% -6.64%
% of Gross Profit 10.15% 11.2% 14.15%
Operating Expenses $1.151B $1.147B $1.137B
YoY Change 0.35% -1.38% -2.65%
Operating Profit -$950.0M $461.0M $453.0M
YoY Change -306.07% 38.02% -10.47%
Interest Expense $37.00M $46.00M $530.0M
YoY Change -19.57% -26.98% -891.04%
% of Operating Profit 9.98% 117.0%
Other Income/Expense, Net $13.00M $12.00M $22.00M
YoY Change 8.33% 0.0% -1200.0%
Pretax Income -$973.0M $427.0M $815.0M
YoY Change -327.87% 53.05% 241.0%
Income Tax -$1.022B -$203.0M $158.0M
% Of Pretax Income -47.54% 19.39%
Net Earnings $49.00M $629.0M $656.0M
YoY Change -92.21% 185.91% 238.14%
Net Earnings / Revenue 0.11% 1.51% 1.79%
Basic Earnings Per Share
Diluted Earnings Per Share $174.4K $2.132M $2.239M
COMMON SHARES
Basic Shares Outstanding 279.0M shares 294.0M shares 292.0M shares
Diluted Shares Outstanding 281.0M shares 295.0M shares

Balance Sheet

Concept 2021 Q4 2020 Q4 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.161B $3.737B $2.771B
YoY Change -15.41% 125.26% 9.48%
Cash & Equivalents $3.161B $3.737B $2.771B
Short-Term Investments
Other Short-Term Assets $4.339B $3.205B $1.707B
YoY Change 35.38% 60.41% -12.28%
Inventory $14.94B $14.44B $13.20B
Prepaid Expenses
Receivables $9.406B $8.728B $8.264B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.85B $30.11B $25.94B
YoY Change 5.76% 17.01% 0.75%
LONG-TERM ASSETS
Property, Plant & Equipment $2.321B $2.386B $2.366B
YoY Change -2.72% 3.69% 0.42%
Goodwill $6.656B $8.399B $8.357B
YoY Change -20.75% 0.51% -0.25%
Intangibles $1.943B $2.703B $2.918B
YoY Change -28.12% -14.65% -14.93%
Long-Term Investments
YoY Change
Other Assets $913.0M $1.118B $1.185B
YoY Change -18.34% -24.56% 12.64%
Total Long-Term Assets $11.83B $14.61B $14.83B
YoY Change -18.99% -4.57% -2.56%
TOTAL ASSETS
Total Short-Term Assets $31.85B $30.11B $25.94B
Total Long-Term Assets $11.83B $14.61B $14.83B
Total Assets $43.68B $44.72B $40.77B
YoY Change -2.32% 8.96% -0.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.76B $23.24B $21.37B
YoY Change 6.56% 8.07% -0.75%
Accrued Expenses $2.669B $2.502B $2.231B
YoY Change 6.67% 11.75% 5.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $301.0M $13.00M $10.00M
YoY Change 2215.38% -98.91% -97.79%
Total Short-Term Liabilities $27.73B $25.75B $23.62B
YoY Change 7.69% 3.46% -2.05%
LONG-TERM LIABILITIES
Long-Term Debt $5.342B $6.720B $6.765B
YoY Change -20.51% -0.33% -10.74%
Other Long-Term Liabilities $341.0M
YoY Change
Total Long-Term Liabilities $5.342B $6.720B $7.106B
YoY Change -20.51% -4.9% -6.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.73B $25.75B $23.62B
Total Long-Term Liabilities $5.342B $6.720B $7.106B
Total Liabilities $42.68B $42.75B $38.98B
YoY Change -0.15% 6.76% 12.54%
SHAREHOLDERS EQUITY
Retained Earnings $1.245B $1.255B $1.170B
YoY Change -0.8% 179.51% -78.47%
Common Stock $2.721B $2.778B $2.789B
YoY Change -2.05% 0.94% 0.94%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.883B $2.009B $2.066B
YoY Change 43.5% -4.29% 15.42%
Treasury Stock Shares 50.00M shares 33.00M shares 34.00M shares
Shareholders Equity $998.0M $1.971B $1.789B
YoY Change
Total Liabilities & Shareholders Equity $43.68B $44.72B $40.77B
YoY Change -2.32% 8.96% -0.48%

Cashflow Statement

Concept 2021 Q4 2020 Q4 2020 Q2
OPERATING ACTIVITIES
Net Income $49.00M $629.0M $656.0M
YoY Change -92.21% 185.91% 238.14%
Depreciation, Depletion And Amortization $164.0M $199.0M $225.0M
YoY Change -17.59% -13.48% -6.64%
Cash From Operating Activities $1.195B $1.217B $240.0M
YoY Change -1.81% 74.61% -52.57%
INVESTING ACTIVITIES
Capital Expenditures -$74.00M -$96.00M -$136.0M
YoY Change -22.92% 24.68% 0.0%
Acquisitions
YoY Change
Other Investing Activities $27.00M -$1.000M $878.0M
YoY Change -2800.0% 0.0% -2472.97%
Cash From Investing Activities -$47.00M -$97.00M $742.0M
YoY Change -51.55% 24.36% -528.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -444.0M -146.0M -528.0M
YoY Change 204.11% -16.57% -57.52%
NET CHANGE
Cash From Operating Activities 1.195B 1.217B 240.0M
Cash From Investing Activities -47.00M -97.00M 742.0M
Cash From Financing Activities -444.0M -146.0M -528.0M
Net Change In Cash 704.0M 974.0M 454.0M
YoY Change -27.72% 119.37% -149.89%
FREE CASH FLOW
Cash From Operating Activities $1.195B $1.217B $240.0M
Capital Expenditures -$74.00M -$96.00M -$136.0M
Free Cash Flow $1.269B $1.313B $376.0M
YoY Change -3.35% 69.64% -41.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000721371
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
dei Entity Shell Company
EntityShellCompany
false
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-11373
dei Entity Registrant Name
EntityRegistrantName
Cardinal Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0958666
dei Entity Address Address Line1
EntityAddressAddressLine1
7000 Cardinal Place
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43017
dei City Area Code
CityAreaCode
(614)
dei Local Phone Number
LocalPhoneNumber
757-5000
dei Security12b Title
Security12bTitle
Common shares (without par value)
dei Trading Symbol
TradingSymbol
CAH
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
277061392 shares
CY2021Q4 us-gaap Revenues
Revenues
45457000000 USD
CY2020Q4 us-gaap Revenues
Revenues
41541000000 USD
us-gaap Revenues
Revenues
89425000000 USD
us-gaap Revenues
Revenues
80606000000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43841000000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39765000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
86167000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
77115000000 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
1616000000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
1776000000 USD
us-gaap Gross Profit
GrossProfit
3258000000 USD
us-gaap Gross Profit
GrossProfit
3491000000 USD
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1151000000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1147000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2265000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2284000000 USD
CY2021Q4 us-gaap Restructuring Charges
RestructuringCharges
7000000 USD
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
20000000 USD
us-gaap Restructuring Charges
RestructuringCharges
25000000 USD
us-gaap Restructuring Charges
RestructuringCharges
57000000 USD
CY2021Q4 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
79000000 USD
CY2020Q4 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
116000000 USD
cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
158000000 USD
cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
234000000 USD
CY2021Q4 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1295000000 USD
CY2020Q4 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1293000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-9000000 USD
CY2021Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-34000000 USD
CY2020Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-32000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-52000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1070000000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-950000000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
461000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-535000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-163000000 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000000 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
37000000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
46000000 USD
us-gaap Interest Expense
InterestExpense
77000000 USD
us-gaap Interest Expense
InterestExpense
91000000 USD
CY2021Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 USD
CY2021Q4 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1000000 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1000000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-973000000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
427000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-604000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-236000000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1022000000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-203000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-925000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-613000000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
49000000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
630000000 USD
us-gaap Profit Loss
ProfitLoss
321000000 USD
us-gaap Profit Loss
ProfitLoss
377000000 USD
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
49000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
629000000 USD
us-gaap Net Income Loss
NetIncomeLoss
320000000 USD
us-gaap Net Income Loss
NetIncomeLoss
376000000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.17
CY2020Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.14
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.13
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.28
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.17
CY2020Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.12
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.27
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
279000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
283000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
293000000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
281000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
285000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295000000 shares
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4908
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4859
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.9816
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.9718
CY2021Q4 us-gaap Profit Loss
ProfitLoss
49000000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
630000000 USD
us-gaap Profit Loss
ProfitLoss
321000000 USD
us-gaap Profit Loss
ProfitLoss
377000000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-43000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
33000000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-6000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
13000000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-8000000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
18000000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-24000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
34000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-51000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
51000000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
25000000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
664000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
270000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
428000000 USD
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25000000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
663000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
269000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
427000000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3161000000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3407000000 USD
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
9406000000 USD
CY2021Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
9103000000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
14941000000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
14594000000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4339000000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2843000000 USD
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
0 USD
CY2021Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
1101000000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
31847000000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
31048000000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2321000000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2360000000 USD
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
8599000000 USD
CY2021Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
10094000000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
913000000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
951000000 USD
CY2021Q4 us-gaap Assets
Assets
43680000000 USD
CY2021Q2 us-gaap Assets
Assets
44453000000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24759000000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
23700000000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
301000000 USD
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
871000000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2669000000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2957000000 USD
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
0 USD
CY2021Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
96000000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27729000000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
27624000000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5342000000 USD
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5365000000 USD
CY2021Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
9607000000 USD
CY2021Q2 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
9670000000 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2721000000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
2806000000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1245000000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1205000000 USD
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
50000000 shares
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
36000000 shares
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2883000000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
937000000 USD
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2186000000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-85000000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34000000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
998000000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1791000000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
4000000 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
3000000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1002000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1794000000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43680000000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44453000000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1396000000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
49000000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
49000000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-24000000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-24000000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19000000 USD
CY2021Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
300000000 USD
CY2021Q4 us-gaap Dividends
Dividends
139000000 USD
CY2021Q4 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1002000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1425000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
629000000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
630000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
34000000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
30000000 USD
CY2020Q4 us-gaap Dividends
Dividends
144000000 USD
CY2020Q4 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1975000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1794000000 USD
us-gaap Net Income Loss
NetIncomeLoss
320000000 USD
us-gaap Profit Loss
ProfitLoss
321000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-51000000 USD
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1000000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18000000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
800000000 USD
us-gaap Dividends
Dividends
280000000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
0 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1002000000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1792000000 USD
us-gaap Net Income Loss
NetIncomeLoss
376000000 USD
us-gaap Profit Loss
ProfitLoss
377000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
51000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
46000000 USD
us-gaap Dividends
Dividends
289000000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-2000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1975000000 USD
us-gaap Profit Loss
ProfitLoss
321000000 USD
us-gaap Profit Loss
ProfitLoss
377000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
332000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
404000000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1000000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1293000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-9000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
42000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
51000000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25000000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
35000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
329000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
499000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
361000000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
932000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1256000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1059000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1861000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1842000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-504000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
549000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1487000000 USD
cah Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
938000000 USD
cah Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
141000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
174000000 USD
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
4000000 USD
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
18000000 USD
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
22000000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
854000000 USD
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
4000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
815000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-191000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
592000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
49000000 USD
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
-27000000 USD
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
-6000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
289000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
289000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
800000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1708000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-344000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-11000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
14000000 USD
cah Cash Reclassified To Asset Held For Sale
CashReclassifiedToAssetHeldForSale
109000000 USD
cah Cash Reclassified To Asset Held For Sale
CashReclassifiedToAssetHeldForSale
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-246000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
966000000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3407000000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2771000000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3161000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3737000000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
849000000 USD
CY2021Q4 us-gaap Severance Costs1
SeveranceCosts1
2000000 USD
CY2020Q4 us-gaap Severance Costs1
SeveranceCosts1
8000000 USD
CY2021Q4 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
5000000 USD
CY2020Q4 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
12000000 USD
CY2021Q4 us-gaap Restructuring Charges
RestructuringCharges
7000000 USD
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
20000000 USD
us-gaap Severance Costs1
SeveranceCosts1
10000000 USD
us-gaap Severance Costs1
SeveranceCosts1
32000000 USD
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
15000000 USD
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
25000000 USD
us-gaap Restructuring Charges
RestructuringCharges
25000000 USD
us-gaap Restructuring Charges
RestructuringCharges
57000000 USD
CY2021Q2 us-gaap Restructuring Reserve
RestructuringReserve
79000000 USD
us-gaap Restructuring Costs
RestructuringCosts
17000000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
34000000 USD
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
62000000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
7989000000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-26000000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1307000000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
6656000000 USD
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.05
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
12000000 USD
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
12000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4905000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2974000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1931000000 USD
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P10Y
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4917000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2974000000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1943000000 USD
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
12000000 USD
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
12000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4916000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2823000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2093000000 USD
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4928000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2823000000 USD
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.476
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.531
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2105000000 USD
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79000000 USD
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
113000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
157000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
228000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
157000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
286000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
262000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
237000000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
210000000 USD
CY2021Q4 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
5600000000 USD
CY2021Q2 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
6200000000 USD
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
24800000000 USD
CY2021Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
23700000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.597
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
45000000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
49000000 USD
CY2021Q4 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
CY2020Q4 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
CY2021Q4 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
5643000000 USD
CY2021Q2 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
6236000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
800000000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
279000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294000000 shares
CY2021Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
281000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
283000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
293000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
285000000 shares
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295000000 shares
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4000000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2021Q4 us-gaap Revenues
Revenues
45457000000 USD
CY2020Q4 us-gaap Revenues
Revenues
41541000000 USD
us-gaap Revenues
Revenues
89425000000 USD
us-gaap Revenues
Revenues
80606000000 USD
CY2021Q4 us-gaap Revenues
Revenues
45457000000 USD
CY2020Q4 us-gaap Revenues
Revenues
41541000000 USD
us-gaap Revenues
Revenues
89425000000 USD
us-gaap Revenues
Revenues
80606000000 USD
CY2021Q4 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
11000000 USD
CY2020Q4 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
6000000 USD
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
18000000 USD
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
11000000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-950000000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
461000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-535000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-163000000 USD
CY2021Q4 us-gaap Assets
Assets
43680000000 USD
CY2021Q2 us-gaap Assets
Assets
44453000000 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18000000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51000000 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2000000 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3000000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
6000000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4000000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
68.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4000000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
69.24
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4000000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
69.41

Files In Submission

Name View Source Status
0000721371-22-000013-index-headers.html Edgar Link pending
0000721371-22-000013-index.html Edgar Link pending
0000721371-22-000013.txt Edgar Link pending
0000721371-22-000013-xbrl.zip Edgar Link pending
a22q2_10qx123121xex1022.htm Edgar Link pending
a22q2_10qx123121xex1032.htm Edgar Link pending
a22q2_10qx123121xex1042.htm Edgar Link pending
a22q2_10qx123121xexhibit107.htm Edgar Link pending
a22q2_10qx123121xexhibit311.htm Edgar Link pending
a22q2_10qx123121xexhibit312.htm Edgar Link pending
a22q2_10qx123121xexhibit321.htm Edgar Link pending
a22q2_10qx123121xexhibit991.htm Edgar Link pending
cah-20211231.htm Edgar Link pending
cah-20211231.xsd Edgar Link pending
cah-20211231_cal.xml Edgar Link unprocessable
cah-20211231_def.xml Edgar Link unprocessable
cah-20211231_g1.jpg Edgar Link pending
cah-20211231_g2.jpg Edgar Link pending
cah-20211231_g3.jpg Edgar Link pending
cah-20211231_g4.jpg Edgar Link pending
cah-20211231_g5.jpg Edgar Link pending
cah-20211231_g6.jpg Edgar Link pending
cah-20211231_g7.jpg Edgar Link pending
cah-20211231_htm.xml Edgar Link completed
cah-20211231_lab.xml Edgar Link unprocessable
cah-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending